Comparison of virus burden in blood and sequential lymph node biopsy specimens from children infected with human immunodeficiency virus

Journal of Pediatrics

Volumn 129, Issue 3, 1996, Pages 410-418

  Mueller, B U ^a   Sei, S ^a   Anderson, B ^a   Luzuriaga, K ^a   Farley, M ^a   Venzon, D J ^a   Tudor Williams, G ^a   Schwartzentruber, D J ^a   Fox, C ^a   Sullivan, J L ^a   Pizzo, P A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; NEVIRAPINE; ZIDOVUDINE;

ARTICLE; CHILD; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; HELPER CELL; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN SITU HYBRIDIZATION; LYMPH NODE BIOPSY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS TITRATION;

EID: 0030396687     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)70074-4     Document Type: Article

References (29)

1. + lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review J Infect Dis 165 1992 352 363
2. KM Butler RN Husson LL Lewis BU Mueller D Venzon PA. Pizzo CD4 status and p24 antigenemia: Are they useful predictors of survival in HIV-infected children receiving antiretroviral therapy? Arch Pediatr Adolesc Med [Am J Dis Child] 146 1992 932 936
3. M Ellaurie A. Rubinstein Beta-2-microglobulin concentrations in pediatric human immunodeficiency virus infection Pediatr Infect Dis J 9 1990 807 809
4. JL Fahey JMG Taylor R Detels The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1 N Engl J Med 322 1990 166 172
5. RE Dickover M Dillon SG Gillette Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants J Infect Dis 170 1994 1279 1284
6. CH Fox K Tenner-Racz P Racz A Firpo PA Pizzo AS. Fauci Lymphoid germinal centers are reservoirs of human immunodeficiency virus type I ILNA J Infect Dis 164 1991 1051 1057
7. G Pantaleo C Graziosi L Butini Lymphoid organs function as major reservoirs for human immunodeficiency virus Proc Natl Acad Sci U S A 88 1991 9838 9842
8. S Sei DE Kleiner JB Kopp Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunodeficiency virus type 1 infection assessed by polymerase chain reaction J Infect Dis 170 1994 325 333
9. Centers for Disease Control Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome MMWR Morbid Mortal Wkly Rep 36 suppl 1s 1987 1S 15S
10. D Havlir SH Cheeseman M McLaughlin High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection J Infect Dis 171 1995 537 545
11. SH Cheeseman SE Hattox MM McLaughlin Pharmacokinetics of nevirapine: initial single-rising-dose study in humans Antimicrob Agents Chemother 37 1993 178 182
12. A Alimenti M O'Neill JL Sullivan K Luzuriaga Diagnosis of vertical human immunodeficency virus type 1 infection by whole blood culture J Infect Dis 166 1992 1146 1148
13. AIDS Clinical Trials Group Virology reference manual 1993 National Institutes of Health Bethesda (MD)
14. S Aoki-Sei H. Mitsuya Quantitative analysis of HIV-1 in clinical specimens from patients with HIV-1 infection by polymerase chain reaction (PCR) J-M Andrieu Viral quantitation in HIV infection. 1991 John Libbey Eurotext Paris 161 170
15. E Kojima T Shirasaka B Anderson Monitoring the activity of antiviral therapy for HIV infection using a polymerase chain reaction method coupled with reverse transcriptase AIDS 7 suppl 2 1993 S101 S105
16. P Biberfeld A Porwit-Ksiazek B Böttiger L Morfeldt-Månsson G Biberfeld Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS Cancer Res 45 suppl 1985 S4665 S4670
17. CH Fox M. Cottier-Fox In situ hybridization in HIV research Microsc Res Tech 25 1993 78 84
18. DD Ho AU Neumann AS Perelson W Chen JM Leonard M. Markowitz Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 373 1995 123 126
19. X Wei SK Ghosh ME Taylor Viral dynamics in human immunodeficiency virus type 1 infection Nature 373 1995 117 122
20. G Pantaleo C Graziosi AS. Fauci The immunopathogenesis of human immunodeficiency virus infection N Engl J Med 328 1993 327 335
21. C Graziosi G Pantaleo JF Demarest HIV-1 infection in the lymphold organs AIDS 7 suppl 2 1993 S53 S58
22. + T-helper cells Am J Pathol 140 1992 15 22
23. AP Burke D Anderson P Mannan Systemic lymphadenopathic histology in human immunodeficiency virus-l-seropositive drug addicts without apparent acquired immunodeficiency syndrome Hum Pathol 25 1994 248 256
24. JM. Coffin HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy Science 267 1995 483 489
25. DD Richman D Havlir J Corbeil Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy J Virol 68 1994 1660 1666
26. RA Koup F Brewster P Grob JL. Sullivan Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin AIDS 7 1993 1181 1184
27. D Richman AS Rosenthai M Skoog BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine Antimicrob Agents Chemother 35 1991 305 308
28. Y-K Chow MS Hirsch DP Merrill Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy Nature 361 1993 650 654
29. MD de Jong M Loewenthal CAB Boucher Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activity J Infect Dis 169 1994 1346 1350